Halozyme Therapeutics shares owned by Pier Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pier Capital
from 13F filings
Historical chart of Pier Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Pier Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Pier Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.3M | 145k | 57.24 |
| 2024-06-30 | $12M | 220k | 52.36 |
| 2024-03-31 | $9.1M | 223k | 40.68 |
| 2023-12-31 | $4.8M | 130k | 36.96 |
| 2023-09-30 | $5.0M | 132k | 38.20 |
| 2023-06-30 | $4.9M | 136k | 36.07 |
| 2023-03-31 | $3.4M | 88k | 38.19 |
| 2022-12-31 | $9.7M | 171k | 56.90 |
| 2022-09-30 | $6.8M | 173k | 39.54 |